Menu

ASLAN Pharmaceuticals Limited ASLN

Full chart Compare
Set alert

Price alert · ASLN

All alert types
0.60 +0.60

Day range unavailable

52-week range unavailable

Revenue & Expenses

Other Income → Expenses: $3.98MExpenses → Selling, General & Admin: $13.24MExpenses → Research & Development: $42.50MExpenses → Interest Expense: $4.33MExpenses → Income Tax: $132.67KGross Profit → Expenses: $12.00MRevenue → Gross Profit: $12.00MNet Loss → Expenses: $44.22MOther Income$3.98MGross Profit$12.00MNet Loss$44.22MExpenses$60.20MSelling, General & Admin$13.24MResearch & Development$42.50MInterest Expense$4.33MIncome Tax$132.67KRevenue$12.00M

Latest period ending Dec 31, 2023 · select a line to chart its full history

Annual income statement

ASLN annual income statement
Fiscal yearFY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020FY 2019 Dec 31, 2019
12.00M0003.00M
12.00M0003.00M
12.00M0002.59M
55.74M47.88M33.85M16.48M48.17M
42.50M38.00M22.02M9.31M16.59M
13.24M9.88M11.83M7.17M8.51M
-43.74M-47.88M-33.85M-16.48M-45.58M
4.33M3.68M1.86M1.25M901.61K
132.67K99.22K00408.00K
-44.22M-51.38M-31.59M-16.97M-47.07M
-44.22M-51.38M-31.59M-16.97M-47.07M
-44.22M-51.38M-31.59M-16.97M-47.07M
-44.22M-51.38M-31.59M-16.97M-47.07M
-22.00-30.00-20.00-16.00-58.00
-22.00-30.00-20.00-16.00-58.00
-22.00-30.00-20.00-16.00-58.00
-39.76M-47.61M-29.73M-15.72M-45.76M
-39.76M-47.61M-29.73M-15.72M-45.76M
411.24M348.72M325.68M192.23M162.39M
411.24M348.72M325.68M192.23M162.39M